S&P 5007,765.36▼0.5% Nasdaq27,193.34▼1.2% Dow51,231.64▲0.1% Russell 2K2,794.13▲0.0% 10-Yr5.23%−5bp VIX15.41+0.33 WTI$91.10▲3.2% Gold$4,157.80▲0.4% EUR/USD1.122▼0.3% BTC$81,907▼1.4% Nikkei70,036▼0.9%
At close · Thu, Oct 8, 2026
Daily Market Updates.

US Markets

Home›US Markets›Sectors›Eli Lilly nears a new buy point after strong earnings

Eli Lilly nears a new buy point after strong earnings

Thursday, August 13, 2026 · Written up by our desk · Sectors

Obesity-drug leader Eli Lilly (LLY) is approaching a new buy point after a strong quarterly earnings update, according to Yahoo Finance.

The article frames the move as a potential entry setup tied to post-earnings momentum toward a technical buy level, but it does not provide additional specific figures in the text available here.

← Newer storyBerkshire Hathaway accelerates share buybacks, spending $4.5 billion…

More like this

US MarketsRising rates are clouding sentiment for big banks on Wall Street
US MarketsRetailers urge UK chancellor to reduce cost of employing young workers
US MarketsRegulators seek contempt finding against Martin Shkreli
US MarketsOptions to fund Social Security are being weighed as insolvency nears
US MarketsCompanies pull back on rushed AI adoption as errors drain worker time

Sources

Yahoo FinanceIBD 50 Stocks To Watch: Obesity Drug Giant Eli Lilly Offers New Buy Point

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.